Primary Site >> Colorectal Cancer
Gene >> RAB1A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. PMID: 15108025 |
Ref: A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. PMID: 15894548 Ref: Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision. PMID: 16273666 |
Ref: Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? PMID: 16532432 |
Ref: Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy. PMID: 17278216 Ref: Local excision after radio(chemo)therapy for rectal cancer: is it safe? PMID: 17766096 |
Ref: Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. PMID: 18163173 Ref: cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. PMID: 18202411 |
Ref: Transanal endoscopic microsurgery for rectal tumors: experience at Korea's National Cancer Center. PMID: 19347399 Ref: Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: is it essential for patients with ypT0-2N0? PMID: 19582821 |
Ref: Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye? PMID: 20173469 Ref: Laparoscopic transanal abdominal transanal resection with sphincter preservation for rectal cancer in the distal 3 cm of the rectum after neoadjuvant therapy. PMID: 20414681 Ref: Local excision following pre-operative chemoradiotherapy-induced downstaging for selected cT3 distal rectal cancer. PMID: 20457724 |
Ref: Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation. PMID: 20842458 Ref: Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. PMID: 21347783 Ref: Clinical impact of tumor regression grade after preoperative chemoradiation for locally advanced rectal cancer: subset analyses in lymph node negative patients. PMID: 21431095 Ref: Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision. PMID: 21590450 |
Ref: Avoiding radical surgery after pre-operative chemoradiotherapy: a possible therapeutic option in rectal cancer? PMID: 22150079 Ref: Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. PMID: 22493423 |
Ref: Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study. PMID: 23187748 Ref: Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. PMID: 23222274 Ref: Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. PMID: 23303140 Ref: Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer. PMID: 23303141 Ref: Ultrasound elastography in patients with rectal cancer treated with chemoradiation. PMID: 23410908 Ref: MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy? PMID: 24074924 Ref: Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. PMID: 24089344 Ref: [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy]. PMID: 24332061 |
Ref: Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation. PMID: 7340717 Ref: Depth and lateral spread of microscopic residual rectal cancer after neoadjuvant chemoradiation: implications for treatment decisions. PMID: 24593015 Ref: [Expression profile of genes associated with the histaminergic system estimated by oligonucleotide microarray analysis HG-U133A in women with endometrial adenocarcinoma]. PMID: 24783427 Ref: Fragmented pattern of tumor regression and lateral intramural spread may influence margin appropriateness after TEM for rectal cancer following neoadjuvant CRT. PMID: 24862927 Ref: Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically T2 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06). PMID: 25038759 Ref: Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter? PMID: 25285691 Ref: Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation. PMID: 25400468 Ref: Rab1A is an mTORC1 activator and a colorectal oncogene. PMID: 25446900 Ref: mTORC1 gRABs the Golgi. PMID: 25517745 |
Ref: Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients. PMID: 25418551 Ref: Regional lymph node status after neoadjuvant chemoradiation of rectal cancer producing a complete or near complete rectal wall response. PMID: 25605475 Ref: The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy. PMID: 25687534 Ref: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study). PMID: 25847025 Ref: Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. PMID: 26474521 Ref: YpT1-2N0 rectal cancer after neoadjuvant chemoradiation has lower survival compared with pT1-2N0 rectal cancer. PMID: 26517674 |
Ref: PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer. PMID: 26434594 Ref: Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup. PMID: 27050599 Ref: [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?]. PMID: 27106241 Ref: Transanal endoscopic operation for rectal cancer after neoadjuvant therapy. PMID: 27142902 Ref: Multicentre study of short-course radiotherapy and transanal endoscopic microsurgery for early rectal cancer. PMID: 27146472 Ref: Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis. PMID: 27196490 Ref: Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer. PMID: 27509881 Ref: A Systematic Review of Local Excision After Neoadjuvant Therapy for Rectal Cancer: Are ypT0 Tumors the Limit? PMID: 27602930 Ref: Synchronous Type 1 Papillary Renal Cell Carcinoma in a Patient with Rectal Adenocarcinoma. PMID: 27630335 Ref: [Retrospective analysis of carcinomas of the rectum operated by TEM during one year at our institute]. PMID: 27991016 |
Ref: Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer. PMID: 26083556 Ref: Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells. PMID: 28184936 Ref: Transanal Minimally-Invasive Surgery for Treating Patients With Regressed Rectal Cancer After Preoperative Chemoradiotherapy. PMID: 28503516 Ref: Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer. PMID: 28583790 |
Ref: Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer. PMID: 29893988 Ref: Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials. PMID: 29929861 Ref: Down-staging depth score to predict outcomes in locally advanced rectal cancer achieving ypI stage after neoadjuvant chemo-radiotherapy versus de novo stage pI cohort: A propensity score-matched analysis. PMID: 30046231 Ref: Aberrant expression of Rab1A and its prognostic significance in human colorectal cancer. PMID: 30058685 |